461 related articles for article (PubMed ID: 8248282)
1. Neuropharmacology of quinolinic and kynurenic acids.
Stone TW
Pharmacol Rev; 1993 Sep; 45(3):309-79. PubMed ID: 8248282
[TBL] [Abstract][Full Text] [Related]
2. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
3. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
Sas K; Robotka H; Toldi J; Vécsei L
J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
[TBL] [Abstract][Full Text] [Related]
4. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities.
Schwarcz R; Pellicciari R
J Pharmacol Exp Ther; 2002 Oct; 303(1):1-10. PubMed ID: 12235226
[TBL] [Abstract][Full Text] [Related]
5. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
Fatokun AA; Smith RA; Stone TW
Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid levels of kynurenine pathway metabolites in patients with eating disorders: relation to clinical and biochemical variable.
Demitrack MA; Heyes MP; Altemus M; Pigott TA; Gold PW
Biol Psychiatry; 1995 Apr; 37(8):512-20. PubMed ID: 7542489
[TBL] [Abstract][Full Text] [Related]
7. Putative NMDA receptors in Hydra: a biochemical and functional study.
Pierobon P; Sogliano C; Minei R; Tino A; Porcu P; Marino G; Tortiglione C; Concas A
Eur J Neurosci; 2004 Nov; 20(10):2598-604. PubMed ID: 15548203
[TBL] [Abstract][Full Text] [Related]
8. Endogenous kynurenate controls the vulnerability of striatal neurons to quinolinate: Implications for Huntington's disease.
Sapko MT; Guidetti P; Yu P; Tagle DA; Pellicciari R; Schwarcz R
Exp Neurol; 2006 Jan; 197(1):31-40. PubMed ID: 16099455
[TBL] [Abstract][Full Text] [Related]
9. Induction of the kynurenine pathway by neurotropic influenza A virus infection.
Holtze M; Asp L; Schwieler L; Engberg G; Karlsson H
J Neurosci Res; 2008 Dec; 86(16):3674-83. PubMed ID: 18655201
[TBL] [Abstract][Full Text] [Related]
10. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
11. [Kynurenine and its metabolites in nervous system diseases].
Vécsei L; Schwab F
Orv Hetil; 1992 Jul; 133(29):1803-7. PubMed ID: 1386152
[TBL] [Abstract][Full Text] [Related]
12. [Biochemical studies on AIDS dementia complex--possible contribution of quinolinic acid during brain damage].
Saito K
Rinsho Byori; 1995 Sep; 43(9):891-901. PubMed ID: 7474452
[TBL] [Abstract][Full Text] [Related]
13. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
14. [Role of excitatory amino acids in neuropathology].
Wikinski SI; Acosta GB
Medicina (B Aires); 1995; 55(4):355-65. PubMed ID: 8728878
[TBL] [Abstract][Full Text] [Related]
15. In situ-produced 7-chlorokynurenate has different effects on evoked responses in rats with limbic epilepsy in comparison to naive controls.
Zhang DX; Williamson JM; Wu HQ; Schwarcz R; Bertram EH
Epilepsia; 2005 Nov; 46(11):1708-15. PubMed ID: 16302850
[TBL] [Abstract][Full Text] [Related]
16. The "kynurenate test", a biochemical assay for putative cognition enhancers.
Pittaluga A; Vaccari D; Raiteri M
J Pharmacol Exp Ther; 1997 Oct; 283(1):82-90. PubMed ID: 9336311
[TBL] [Abstract][Full Text] [Related]
17. Increased ratio of quinolinic acid to kynurenic acid in cerebrospinal fluid of D retrovirus-infected rhesus macaques: relationship to clinical and viral status.
Heyes MP; Mefford IN; Quearry BJ; Dedhia M; Lackner A
Ann Neurol; 1990 Jun; 27(6):666-75. PubMed ID: 2163238
[TBL] [Abstract][Full Text] [Related]
18. The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.
Vamos E; Pardutz A; Klivenyi P; Toldi J; Vecsei L
J Neurol Sci; 2009 Aug; 283(1-2):21-7. PubMed ID: 19268309
[TBL] [Abstract][Full Text] [Related]
19. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
20. N-methyl-D-aspartate autoreceptors respond to low and high agonist concentrations by facilitating, respectively, exocytosis and carrier-mediated release of glutamate in rat hippocampus.
Luccini E; Musante V; Neri E; Raiteri M; Pittaluga A
J Neurosci Res; 2007 Dec; 85(16):3657-65. PubMed ID: 17671992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
